| abstract |
A process for the production of an N-sulfanilyl-cytosine compound, which has the formula ** (See formula) ** and pharmaceutically acceptable alkali metal salts thereof, characterized in that an acylated N-sulfanylyl-cytosine compound having the formula is hydrolyzed. ** (See formula) ** wherein R is lower alkyl, lower alkoxyalkyl, lower alkenyl, or lower alkyl substituted by phenyl; and Acyl represents an acyl radical. (Machine-translation by Google Translate, not legally binding) |